 | | PATHWAY: ko04148 | |
Entry |
|
Name |
Efferocytosis |
Class |
Cellular Processes; Transport and catabolism
|
Pathway map |

|
Orthology |
K00411 | UQCRFS1, RIP1, petA; ubiquinol-cytochrome c reductase iron-sulfur subunit [EC:7.1.1.8] |
K01052 | LIPA; lysosomal acid lipase/cholesteryl ester hydrolase [EC:3.1.1.13] |
K01581 | E4.1.1.17, ODC1, speC, speF; ornithine decarboxylase [EC:4.1.1.17] |
K03986 | C1QA; complement C1q subcomponent subunit A |
K03987 | C1QB; complement C1q subcomponent subunit B |
K03988 | C1QG; complement C1q subcomponent subunit C |
K04192 | CX3CR1; CX3C chemokine receptor 1 |
K04259 | PTGER2; prostaglandin E receptor 2 |
K04261 | PTGER4; prostaglandin E receptor 4 |
K04269 | P2RY2; P2Y purinoceptor 2 |
K04272 | P2RY6; P2Y purinoceptor 6 |
K04288 | S1PR1, EDG1, CD363; sphingosine 1-phosphate receptor 1 |
K04298 | P2RY12; P2Y purinoceptor 12 |
K04368 | MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] |
K04369 | MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] |
K04392 | RAC1; Ras-related C3 botulinum toxin substrate 1 |
K04438 | CRK, CRKII; C-crk adapter molecule crk |
K04443 | MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1] |
K04446 | NFATC1, NFAT2, NFATC; nuclear factor of activated T-cells, cytoplasmic 1 |
K04504 | NR1C2, PPARD; peroxisome proliferator-activated receptor delta |
K04515 | CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] |
K04550 | LRP1, CD91; low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor) |
K04596 | ADGRB1, BAI1; adhesion G protein-coupled receptor B1 |
K05079 | EPOR; erythropoietin receptor |
K05443 | IL10, CSIF; interleukin 10 |
K05464 | GAS6; growth arrest-specific 6 |
K05508 | CX3CL1, NTT; C-X3-C motif chemokine 1 |
K05641 | ABCA1; ATP-binding cassette, subfamily A (ABC1), member 1 |
K05697 | PTPN6, SHP1; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48] |
K05726 | BCAR1, CAS; breast cancer anti-estrogen resistance 1 |
K05870 | CREB1; cyclic AMP-responsive element-binding protein 1 |
K06059 | ADAM17, TACE, CD156b; disintegrin and metalloproteinase domain-containing protein 17 [EC:3.4.24.86] |
K06266 | CD47; CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
K06471 | PECAM1, CD31; platelet/endothelial cell adhesion molecule |
K06487 | ITGAV, CD51; integrin alpha V |
K06493 | ITGB3, CD61; integrin beta 3 |
K06551 | SIRPA_B1_G, CD172; signal-regulatory protein alpha/beta1/gamma |
K06704 | ADAM10, CD156c; disintegrin and metalloproteinase domain-containing protein 10 [EC:3.4.24.81] |
K06749 | SIGLEC10; sialic acid binding Ig-like lectin 10 |
K06834 | ADAM9; disintegrin and metalloproteinase domain-containing protein 9 [EC:3.4.24.-] |
K07293 | PTPN11, SHP2; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48] |
K07299 | SLC2A1, GLUT1; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 1 |
K07881 | RAB14; Ras-related protein Rab-14 |
K07887 | RAB5A; Ras-related protein Rab-5A |
K07888 | RAB5B; Ras-related protein Rab-5B |
K07889 | RAB5C; Ras-related protein Rab-5C |
K07897 | RAB7A; Ras-related protein Rab-7A |
K07898 | RAB7B; Ras-related protein Rab-7B |
K07909 | RAB17; Ras-related protein Rab-17 |
K08179 | SLC16A1; MFS transporter, MCT family, solute carrier family 16 (monocarboxylic acid transporters), member 1 |
K08268 | HIF1A; hypoxia-inducible factor 1 alpha |
K08426 | GPR132, G2A; G protein-coupled receptor 132 |
K08524 | RXRA, NR2B1; retinoid X receptor alpha |
K08530 | NR1C3, PPARG; peroxisome proliferator-activated receptor gamma |
K08535 | NR1H2, LXRB; liver X receptor beta |
K08536 | NR1H3, LXRA; liver X receptor alpha |
K08765 | CPT1A; carnitine O-palmitoyltransferase 1, liver isoform [EC:2.3.1.21] |
K09097 | ARNT; aryl hydrocarbon receptor nuclear translocator |
K09355 | PBX1; pre-B-cell leukemia transcription factor 1 |
K10048 | CEBPB; CCAAT/enhancer binding protein (C/EBP), beta |
K11411 | SIRT1, SIR2L1; NAD-dependent protein deacetylase sirtuin 1 [EC:2.3.1.286] |
K12366 | ELMO1, CED12; engulfment and cell motility protein 1 |
K13375 | TGFB1; transforming growth factor beta-1 |
K13708 | DOCK1; dedicator of cytokinesis protein 1 |
K14802 | DRS2, ATP8A; phospholipid-transporting ATPase [EC:7.6.2.1] |
K16343 | PLA2G6, IPLA2; calcium-independent phospholipase A2 [EC:3.1.1.4] |
K16857 | THBS1; thrombospondin 1 |
K17332 | NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic 2 |
K17333 | NFATC3, NFAT4; nuclear factor of activated T-cells, cytoplasmic 3 |
K17334 | NFATC4, NFAT3; nuclear factor of activated T-cells, cytoplasmic 4 |
K19013 | STAB2, HARE; stabilin-2 |
K19480 | ANO5, GDD1, TMEM16E; anoctamin-5 |
K19498 | ANO3, TMEM16C; anoctamin-3 |
K19499 | ANO4, TMEM16D; anoctamin-4 |
K19500 | ANO6, TMEM16F; anoctamin-6 |
K19501 | ANO7, NGEP, TMEM16G; anoctamin-7 |
K19503 | ANO9, TMEM16J; anoctamin-9 |
K19523 | CPT1B; carnitine O-palmitoyltransferase 1, muscle isoform [EC:2.3.1.21] |
K19524 | CPT1C; carnitine O-palmitoyltransferase 1, brain isoform [EC:2.3.1.21] |
K19722 | AGER, RAGE; receptor for advanced glycosylation end products |
K20177 | VPS3, TGFBRAP1; vacuolar protein sorting-associated protein 3 |
K20178 | VPS8; vacuolar protein sorting-associated protein 8 |
K20179 | VPS11, PEP5; vacuolar protein sorting-associated protein 11 |
K20180 | VPS16; vacuolar protein sorting-associated protein 16 |
K20181 | VPS18, PEP3; vacuolar protein sorting-associated protein 18 |
K20182 | VPS33A; vacuolar protein sorting-associated protein 33A |
K20183 | VPS39, VAM6; Vam6/Vps39-like protein vacuolar protein sorting-associated protein 39 |
K20184 | VPS41; vacuolar protein sorting-associated protein 41 |
K20413 | HAVCR1, CD365; hepatitis A virus cellular receptor 1 |
K20414 | HAVCR2, CD366; hepatitis A virus cellular receptor 2 |
K23285 | GULP1, CED6; PTB domain-containing engulfment adapter protein 1 |
K23678 | PQLC2, SLC66A1, LAAT1; solute carrier family 66 (lysosomal lysine-arginine transporter), member 1 |
K24068 | MEGF10_11; multiple epidermal growth factor-like domains protein 10/11 |
K24318 | SCARF1; scavenger receptor class F member 1 |
K26811 | XKR4_6_7; XK-related protein 4/6/7 |
K26813 | XKR8; XK-related protein 8 |
K26814 | XKR9; XK-related protein 9 |
K26934 | ATP11; phospholipid-transporting ATPase |
K26935 | TMEM30, CDC50; cell cycle control protein 50 |
K26936 | TIMD4, TIM4; T-cell immunoglobulin and mucin domain-containing protein 4 |
|
Compound |
C00019 | S-Adenosyl-L-methionine |
C04230 | 1-Acyl-sn-glycero-3-phosphocholine |
C06124 | Sphingosine 1-phosphate |
C15610 | Cholest-5-ene-3beta,26-diol |
|
Reference |
|
Authors |
Doran AC, Yurdagul A Jr, Tabas I |
Title |
Efferocytosis in health and disease. |
Journal |
|
Reference |
|
Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
Journal |
|
Reference |
|
Authors |
Kawano M, Nagata S |
Title |
Efferocytosis and autoimmune disease. |
Journal |
|
Reference |
|
Authors |
Mehrotra P, Ravichandran KS |
Title |
Drugging the efferocytosis process: concepts and opportunities. |
Journal |
|
Reference |
|
Authors |
Park SY, Kim IS |
Title |
Engulfment signals and the phagocytic machinery for apoptotic cell clearance. |
Journal |
|
Reference |
|
Authors |
Kojima Y, Weissman IL, Leeper NJ |
Title |
The Role of Efferocytosis in Atherosclerosis. |
Journal |
|
Related pathway |
ko00010 | Glycolysis / Gluconeogenesis |
|
|
|